Skip to main content

Table 2 Adverse events characteristics

From: Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events

Variable First 12 months Last 12 months Whole study period
No. of AEs 1071 976 2047
Person reporting, n (%)    
  Nurse 869 (81) 888 (91) 1757 (86)
  MD 190 (18) 79 (8) 269 (13)
  Other 12 (1) 9 (1) 21 (1)
Role of reporter, n (%)    
  Eye-witnessed the AE 494 (46) 509 (52) 1003 (49)
  Involved in AE occurrence 395 (37) 321 (33) 716 (35)
  Was called for help 138 (13) 129 (13) 267 (13)
  Missing data 30 (3) 31 (3) 61 (3)
Patients NEMS in AEs questionnaire, n (%)    
  NEMS ≥25 227 (21) 203 (21) 430 (21)
  NEMS 22-24 450 (42) 430 (44) 880 (43)
  NEMS 14-21 302 (28) 251 (26) 553 (27)
  NEMS <14 42(4) 40 (4) 82 (4)
  NEMS, missing data 62 (6) 40 (4) 102 (5)
Patients leading diagnosis in AEs questionnaire, n (%)    
  >1 leading diagnosis 446 (42) 332 (34) 778 (38)
  Respiratory disorders 204 (19) 213 (22) 409 (20)
  Cardiovascular disorders 176 (16) 172 (18) 348 (17)
  Neurological disorders 77 (7) 66 (7) 143 (7)
  Postoperative 60 (6) 63 (6) 123 (6)
  Other 134 (13) 112 (11) 246 (12)
AE categories, n (%)    
  Drug-related 506 (47) 478 (49) 984 (48)
  Indwelling lines, catheters and drains 135 (13) 110 (11) 245 (12)
  Communication and planning 107 (10) 104 (11) 213 (10)
  Airway 100 (9) 88 (9) 188 (9)
  Equipment 75 (7) 89 (9) 164 (8)
  Other procedures (bronchoscopy, EGD, electrical cardioversion…) 75 (7) 60 (6) 135 (7)
  Others (documentation, positioning…) 64 (6) 54 (6) 118 (6)
  1. Data are presented for the pre-implementation period (first 12 months), for the post-implementation period (last 12 months), and for the whole study period (24 months). AE, adverse event; EGD, esophagogastroduodenoscopy; NEMS, nine equivalents of nursing manpower use score; MD, medical doctor.